Signaling Pathways - Cocaine-Related Disorders - Osteoporosis - Type 2 Diabetes - Lung Cancer
清除全部
- B6032 CB-5083Target: p97Summary: p97抑制剂
- B4763 GKT1378311 CitationTarget: NADPH OxidasesSummary: Nox1/Nox4双重抑制剂
- B5978 BDA-366Target: Bcl-2Summary: BCL2 BH4 结构域的选择性拮抗剂
- A8715 SBI-02069652 CitationTarget: ULK1Summary: ULK1抑制剂
- B5836 AZ5104Target: EGFRSummary: EGFR抑制剂
- B4900 Indoximod (NLG-8189)Summary: 吲哚胺2,3-双加氧酶(IDO)途径抑制剂
- B7794 BMS 3094032 CitationTarget: Fatty-acid-binding proteins (FABPs)Summary: FABP4抑制剂
- B5612 BAY 60-6583Target: Adenosine A2B ReceptorsSummary: A2B受体的强效激动剂
- B6988 BRL 50481Target: Phosphodiesterases (PDEs)Summary: PDE7抑制剂
- B6766 CL 316243 disodium saltSummary: 鼠选择性的β3肾上腺素受体激动剂